Systemic Lupus Erythematosus - Vitamin D3 Study
Effect of Vitamin D3 on the IFNa Signature in Patients with Systemic Lupus Erythematosus (Protocol #ALE02)
Protocol ID
08-109
Protocol Description
The purpose of the study is to find out how vitamin D replacement affects the interferon signature in people with systemic lupus erythematosus (SLE).
Eligibility Criteria
Patients with systemic lupus erythematosus (SLE)
Primary Investigator(s)
- Cynthia Aranow, MD
Contact Information
Last Update
April 2, 2010How did I get to this page?
Related Information
- News Room
-
Clinical Trials
- Systemic Lupus Erythematosus - Classification and Criteria (ARoSE) (07.08.049)
- Systemic Lupus Registry (07-053)
- Systemic Lupus Erythematosus - Gene Study (SAGE) (08-205)
- Pulmonary Artery Hypertension - Biomarker Study (07-030)
- Bipolar Disorder - ECT Follow-up Study (04.08.132T)
- Bipolar Disorder - Neurocognitive Study (04.04.105)
- Cystic Fibrosis Patient Registry (02.08.156)
- Systemic Lupus Erythematosus - Pediatric Atherosclerosis Prevention Study (03.10.074T)
- System Lupus Erythematosus - Study of 3.3-Diidolymethane (06.02.107T)
- Rituximab in SLE: Effects of Immune Reconstitution on Treatment Response (06.08.094T)
- Cystic Fibrosis Patient Registry (Pediatrics) (02.08.171)
- Acute Coronary Syndrome Study (06-099T)
- Clinical Correlates of Memory Impairment (03.08.160)
- Alzheimer's Disease - Memantine Study (06.02.108T)
- Normal Control Registry for Current and Future Research (04-007/G)
- Research Recruitment Screening Database (05.08.167T)
- Systemic Lupus Erythematosus - PET/MRI Study (07-012)
- Lupus Nephritis - Clinical Trial (08-197)
- Systemic Lupus Erythematosus - Antibody Study (07-081)
- Cognitive Enhancement in Bipolar Disorder (05-069)
- Schizophrenia - Relapse Prevention Study (05.04.063)
- Autism Spectrum Disorders - Adult Study (07.04.051)
- Bipolar Susceptibility Study (08-132)
- Brain Networks in Parkinson's Disease (04-113T)
- Schizophrenia - Clinical Trial (05.04.086)
- National Marrow Donor Program's Research Sample Repository (03.10.116)
- National Marrow Donor Program Research Database (03.10.117)
- Smoking Cessation - Lozenge vs. Patch (06-030)
- Tissue Banking - Laryngeal and Tracheal Disease (03.02.080)
- Bipolar Disorder - White Matter Integrity Study (02.08.187)
- Stenting and Angioplasty Post-Marketing Study (06-02-281)
- Systemic Lupus Erythematosus - Clinical Trial (07-02-190)
- CF - Expanded Access Study (07-02-201)
- Systemic Lupus Erythematosus - Clinical Trial (07-02-283)
- Systemic Lupus Erythematosus - Clinical Trial (07-02-81)
- Focal Segmental Glomerulosclerosis Study (07-10-238)
- Systemic Lupus Erythematosus - Clinical Trial (08-02-145)
- HIV - Clinical Trial (08-02-160)
- Asthma - Clinical Trial (08-02-188)
- Systemic Lupus Erythematosus - Clinical Trial (08-02-207)
- Cystitis-Painful Bladder Study - (08-269)
- Pelvic Pain Study - (08-274)
- Prediction of Relapse in Schizophrenia - (08-278)
- Schizophrenia - Clinical Trial (08-296)
- Systemic Lupus Erythematosus - Clinical Trial (09-02-112)
- Systemic Lupus Erythematosus - Clinical Trial (09-02-133)
- Cystic Fibrosis - Clinical Trial (09-02-147)
- Cystic Fibrosis - Clinical Trial (09-10-102)
- Systemic Lupus Erythematosus Registry (09-104)
- Bipolar Disorder - Mindfulness Training Study (10-013B)
- Vest Prevention of Early Sudden Death Trial (VEST) and Prediction of ICD Therapies Study (PREDICTS) (09-056)
- Systemic Lupus Erythematosus Study (09-122)
- Genes and Phenotype Study (09-081)
- National Lymphatic Disease and Lymphedema Registry (09-137)
- White Matter Endophenotypes in Bipolar Disorder (09-222)
- Biomarkers in the Evaluation of Chronic Lung Disease (09-076)
General Navigation
Persistent Navigation
-
Clinical Trials
- Addiction
- Aging
- Allergies
- Arthritis
- Autoimmune Disease
- Blood Disorders
- Cancer
- Children's Health
- Circulation
- Dental
- Diabetes
- Ear & Hearing
- Eyes
- Gastrointestinal/Hepatitis
- Genetics
- Heart
- HIV
- Infectious Diseases
- Joints
- Kidney
- Lung
-
Lupus
- Autoimmunity in Sisters of SLE Patients (SisSLE) (09-263)
- Lupus Nephritis - Clinical Trial (08-197)
- Rituximab in SLE: Effects of Immune Reconstitution on Treatment Response (06.08.094T)
- Systemic Lupus Erythematosus - Antibody Study (07-081)
- Systemic Lupus Erythematosus - Classification and Criteria (ARoSE) (07.08.049)
- Systemic Lupus Erythematosus - Clinical Trial (07-02-190)
- Systemic Lupus Erythematosus - Clinical Trial (07-02-283)
- Systemic Lupus Erythematosus - Clinical Trial (07-02-81)
- Systemic Lupus Erythematosus - Clinical Trial (08-02-145)
- Systemic Lupus Erythematosus - Clinical Trial (08-02-207)
- Systemic Lupus Erythematosus - Clinical Trial (09-02-112)
- Systemic Lupus Erythematosus - Clinical Trial (09-02-133)
- Systemic Lupus Erythematosus - Gene Study (SAGE) (08-205)
- Systemic Lupus Erythematosus - Pediatric Atherosclerosis Prevention Study (03.10.074T)
- Systemic Lupus Erythematosus - PET/MRI Study (07-012)
- Systemic Lupus Erythematosus Registry (09-104)
- Systemic Lupus Erythematosus Study (09-122)
- Systemic Lupus Erythematosus - Vitamin D3 Study (08-109)
- Systemic Lupus Registry (07-053)
- System Lupus Erythematosus - Study of 3.3-Diidolymethane (06.02.107T)
- Men's Health
- Mental Health
- Neurosciences
- Recruitment Registry
- Skin
- Sleep Disorders
- Smoking
- Urinary Tract
- Weight Control
- Women's Health